The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies

GA Cirkel; F Weeber; Sander Bins; CG Gadellaa - van Hooijdonk; E van Werkhoven; SM Willems; M van Stralen; WB Veldhuis; I Ubink; N Steeghs; Maja de Jonge; M H G Langenberg; JHM Schellens; Stefan Sleijfer; Martijn Lolkema; EE Voest

doi:10.1093/annonc/mdw223

The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies

GA Cirkel, F Weeber, Sander Bins, CG Gadellaa - van Hooijdonk, E van Werkhoven, SM Willems, M van Stralen, WB Veldhuis, I Ubink, N Steeghs, Maja de Jonge, M H G Langenberg, JHM Schellens, Stefan Sleijfer, Martijn Lolkema, EE Voest

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

16 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1638-1643
Number of pages	6
Journal	Annals of Oncology
Volume	27
Issue number	8
DOIs	https://doi.org/10.1093/annonc/mdw223
Publication status	Published - 2016

Research programs

EMC MM-03-86-01
EMC MM-03-86-08

Access to Document

10.1093/annonc/mdw223

Cite this

Cirkel, GA., Weeber, F., Bins, S., Gadellaa - van Hooijdonk, CG., van Werkhoven, E., Willems, SM., van Stralen, M., Veldhuis, WB., Ubink, I., Steeghs, N., de Jonge, M., Langenberg, M. H. G., Schellens, JHM., Sleijfer, S., Lolkema, M., & Voest, EE. (2016). The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies. Annals of Oncology, 27(8), 1638-1643. https://doi.org/10.1093/annonc/mdw223

@article{36ccaddfcf3643ff85a633d975c947b9,

title = "The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies",

author = "GA Cirkel and F Weeber and Sander Bins and \{Gadellaa - van Hooijdonk\}, CG and \{van Werkhoven\}, E and SM Willems and \{van Stralen\}, M and WB Veldhuis and I Ubink and N Steeghs and \{de Jonge\}, Maja and Langenberg, \{M H G\} and JHM Schellens and Stefan Sleijfer and Martijn Lolkema and EE Voest",

year = "2016",

doi = "10.1093/annonc/mdw223",

language = "Undefined/Unknown",

volume = "27",

pages = "1638--1643",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "8",

}

Cirkel, GA, Weeber, F, Bins, S, Gadellaa - van Hooijdonk, CG, van Werkhoven, E, Willems, SM, van Stralen, M, Veldhuis, WB, Ubink, I, Steeghs, N, de Jonge, M, Langenberg, MHG, Schellens, JHM, Sleijfer, S, Lolkema, M & Voest, EE 2016, 'The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies', Annals of Oncology, vol. 27, no. 8, pp. 1638-1643. https://doi.org/10.1093/annonc/mdw223

TY - JOUR

T1 - The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies

AU - Cirkel, GA

AU - Weeber, F

AU - Bins, Sander

AU - Gadellaa - van Hooijdonk, CG

AU - van Werkhoven, E

AU - Willems, SM

AU - van Stralen, M

AU - Veldhuis, WB

AU - Ubink, I

AU - Steeghs, N

AU - de Jonge, Maja

AU - Langenberg, M H G

AU - Schellens, JHM

AU - Sleijfer, Stefan

AU - Lolkema, Martijn

AU - Voest, EE

PY - 2016

Y1 - 2016

U2 - 10.1093/annonc/mdw223

DO - 10.1093/annonc/mdw223

M3 - Article

C2 - 27234642

SN - 0923-7534

VL - 27

SP - 1638

EP - 1643

JO - Annals of Oncology

JF - Annals of Oncology

IS - 8

ER -